Consensus IDEXX Laboratories, Inc. Sao Paulo

Stocks

I1DX34

BRI1DXBDR001

Medical Equipment, Supplies & Distribution

Market Closed - Sao Paulo 05:37:02 26/09/26 am AEST			5-day change	1st Jan Change
538.10 ^BRL	+1.91%		-.--%	-28.76%

01/10	IDEXX Laboratories Acquires Veterinary AI Platform CoVetAI	MT
17/09	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Economic Data, Fed Rate Hike	MT

34192b48.xxApwfaKvj4BLmrM_YrMQTsDl53lND9LyI1tJtHa35Q.tCJfhJLEjXFiF0eCuLuVJ19uxOmwVgoJq_4ydenuk8OdW02thuHcX2lJDQ~ad078daf9c4b8100bd4ed8d57665e4c4

Analysts' recommendations: IDEXX Laboratories, Inc.

11/08	Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating	MT
06/08	Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792	MT
06/08	Citigroup Adjusts Price Target on IDEXX Laboratories to $670 From $650	MT
05/08	UBS Adjusts Price Target on IDEXX Laboratories to $670 From $620, Maintains Neutral Rating	MT
28/07	Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says	MT
28/07	UBS Cuts IDEXX Laboratories Price Target to $620 From $640, Maintains Neutral Rating	MT
13/07	Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating	MT
06/05	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $665 From $655	MT
06/05	Jefferies Adjusts Price Target on IDEXX Laboratories to $792 From $785	MT
28/04	UBS Adjusts Price Target on IDEXX Laboratories to $640 From $730, Maintains Neutral Rating	MT
27/04	Jefferies Adjusts Price Target on IDEXX Laboratories to $785 From $820, Maintains Buy Rating	MT
15/04	Citigroup Initiates IDEXX Laboratories at Neutral With $650 Price Target	MT
14/04	Leerink Partners Adjusts IDEXX Laboratories PT to $725 From $760, Maintains Outperform Rating	MT
31/03	Stifel Nicolaus Adjusts IDEXX Laboratories PT to $675 From $775, Maintains Buy Rating	MT
09/02	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating	MT
06/02	Barclays Adjusts Price Target on IDEXX Laboratories to $800 From $850, Maintains Overweight Rating	MT
05/02	Barclays Lowers Price Target on IDEXX Laboratories to $800 From $850	MT
04/02	Jefferies Adjusts Price Target on IDEXX Laboratories to $820 From $830	MT
04/02	UBS Adjusts IDEXX Laboratories PT to $730 From $750	MT
03/02	Leerink Partners Adjusts Price Target on IDEXX Laboratories to $760 From $785	MT
03/02	BTIG Adjusts Price Target on IDEXX Laboratories to $800 From $830	MT
03/02	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $655 From $700	MT
10/12	Barclays Initiates IDEXX Laboratories With Overweight Rating, $850 Price Target	MT
11/11	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $775 From $700	MT
05/11	UBS Adjusts Price Target on IDEXX Laboratories to $750 From $710, Maintains Neutral Rating	MT

More recommendations

Veterinary Medical Equipment & Supplies

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
IDEXX LABORATORIES, INC.	-	-	-	-
ABBOTT LABORATORIES				+23.68%
MEDTRONIC PLC				+21.36%
STRYKER CORPORATION				+33.54%
ESSILORLUXOTTICA				+62.89%
CENCORA, INC.				+19.48%
HOYA CORPORATION				+24.9%
BECTON, DICKINSON AND COMPANY				+10.67%
IDEXX LABORATORIES, INC.				+35.29%
DEXCOM, INC.				+11.39%
Average				+27.02%
Weighted average by Cap.				+27.95%